Holding(s) in Company

Dechra Pharmaceuticals PLC
28 December 2007


                                                                    

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES


(1). Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:


DECHRA PHARMACEUTICALS



2. Reason for the notification (please state Yes/No): (   )

An acquisition or disposal of voting rights:                               (YES)

An acquisition or disposal of financial instruments which may result 
in the acquisition of shares already issued to which voting rights are 
attached:                                                                  (   )

An event changing the breakdown of voting rights:                          (   )

Other (please specify) :                                                   (   )


 
3. Full name of person(s) subject to the notification obligation:


SCHRODERS PLC

 

4. Full name of shareholder(s) (if different from 3.):



 

5. Date of the transaction and date on which the threshold is crossed or reached
if different):


21/12/2007

 

6. Date on which issuer notified:


27/12/2007

 

7. Threshold(s) that is/are crossed or reached:


FROM 12% - 11%
 

8. Notified details:


 


A: Voting rights attached to shares

 
Class/type of shares            Situation previous to  
if possible using the           the Triggering         
ISIN CODE                       transaction        

                       Number of shares       Number of voting Rights 


ORDINARY GB0009633180  6,809,023              6,809,023

 

                     Resulting situation after the triggering transaction 
 
Class/type of shares Number of shares  Number of voting rights    % of voting rights  
if possible using                                                                 
the ISIN CODE                                                                         

                                       Direct     Indirect        Direct    Indirect  


ORDINARY GB0009633180       N/A        N/A        6,259,970       N/A       11.85%


B: Financial Instruments

Resulting situation after the triggering transaction 

Type of     Expiration Date  Exercise/Conversion Number of voting     % of voting     
financial                    Period/ Date        rights that may be   rights          
instrument                                       acquired if the                      
                                                 instrument is                        
                                                 exercised/                           
                                                 converted.                           


 

Total (A+B)


Number of voting rights       % of voting rights 


6,259,970                       11.85%
 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:


 
SCHRODER INVESTMENT MANAGEMENT LIMITED                    5,604,851     10.61%

SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA LIMITED        655,119      1.24%


Proxy Voting:

 
10. Name of the proxy holder:


 

11. Number of voting rights proxy holder will cease to hold:


 

12. Date on which proxy holder will cease to hold voting rights:


 

13. Additional information:


THE SHARES REFERRED TO IN SECTION 9 ARE HELD IN PORTFOLIOS MANAGED BY THOSE
FIRMS ON A DISCRETIONARY BASIS FOR CLIENTS UNDER INVESTMENT MANAGEMENT
AGREEMENTS
 

14. Contact name:


VICKY WAND
 

15. Contact telephone number:


020 7658 3750


 
                      This information is provided by RNS
            The company news service from the London Stock Exchange